SEARCH RESULT

Total Matching Records found : 273

Supreme Court refuses to hear challenge on NPPA decision -Apoorva

-Livemint The petition challenged NPPA's decision of withdrawing its internal guideline to set prices of non-essential drugs New Delhi: The Supreme Court on Monday refused to entertain a petition challenging a decision by the country's drug price regulator to withdraw its internal guideline to set prices of non-essential drugs. Earlier this year, the National Pharmaceutical Pricing Authority (NPPA) issued a guideline empowering itself to cap the prices of 108 non-essential drugs, attracting...

More »

Subramanian till recently had opposed India on IPR

-The Times of India The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations. Subramanian...

More »

India to soon manufacture health capsule from tea extract -Vanita Srivastava

-The Hindustan Times   In what can be a boost for the Make in India slogan the industry and lab are entering into new areas of partnership-latest being transfer of technology from a CSIR lab to make multi nutritional health capsule from tea extracts. CSIR-Institute of Himalayan Bioresource Technology, Palampur in Himachal Pradesh has developed technology for extraction of catechins using water and green solvents without using any hazardous chemicals. The technology...

More »

Mala Fide Decision on Drug Prices

-Economic and Political Weekly   The decision to reduce the powers of the drug pricing body goes against the interest of public health. The decision of the Government of India to withdraw the power of the National Pharmaceutical Pricing Authority (NPPA) to set price controls on drugs that are not on the National List of Essential Medicines (NLEM) raises questions on the Narendra Modi regime's commitment to people's welfare. One must ask if...

More »

Drug price tug of war: people vs others -S Srinivasan

-The Hindu Business Line   The media have got it wrong on price control reversal Recently, there has been a flutter in various media channels and newspapers as to how the Modi Government has reversed certain drug price control measures announced in July 2014. As a result, we are told, prices of these drugs would increase much more than pre-July levels. This was supposed to be a sequel to Modi's visit to the...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close